Flusonal 50 micrograms/inhalation, suspension for inhalation in pressurized container

Spain
Brand name Flusonal 50 micrograms/inhalation, suspension for inhalation in pressurized container
Form suspension for inhalation in pressurized container
Active substance / Dosage
Prescription type Prescription Only Medicine
Registration number 60525
Flusonal 50 micrograms/inhalation, suspension for inhalation in pressurized container suspension for inhalation in pressurized container

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Flusonal 50 micrograms/inhalation, inhalation suspension in pressurised container

fluticasone propionate

Read the entire leaflet carefully before you start using this medicine, as it contains important information for you.

  • Keep this leaflet as you may need to read it again.
  • If you have any questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are adverse effects not listed in this leaflet. See section 4.

Contents of the leaflet

  1. What Flusonal 50 micrograms/inhalation is and what it is used for
  2. What you need to know before using Flusonal 50 micrograms/inhalation
  3. How to use Flusonal 50 micrograms/inhalation
  4. Possible side effects
  5. How to store Flusonal 50 micrograms/inhalation
  6. Contents of the pack and other information

1. What Flusonal 50 micrograms/inhalation is and what it is used for

Fluticasone propionate belongs to the group of medicines known as corticosteroids. Corticosteroids are used in the treatment of asthma due to their anti-inflammatory activity. They reduce inflammation and irritation in the walls of the small airways in the lungs, thereby decreasing breathing difficulties. Corticosteroids also help prevent asthma attacks.

Flusonal 50 micrograms/inhalation is recommended for the treatment of mild to severe asthma.

2. What you need to know before using Flusonal 50 micrograms/inhalation

Do not use Flusonal 50 micrograms/inhalation
  • if you are allergic (hypersensitive) to fluticasone propionate or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to use Flusonal 50 micrograms/inhalation:

  • if you have ever had to stop using this or any other medicine for your condition due to allergy or another problem
  • if you notice that you increasingly require higher use of this medicine for adequate symptom control, your treatment should be reviewed
  • if you have ever had mouth ulcers/lesions
  • if you have any liver disease
  • if you have recently received or are receiving treatment for tuberculosis, or if you are taking other corticosteroids orally or by inhalation
  • if you are under periods of high stress or are admitted to hospital following a serious injury or accident, or before undergoing surgery, and are being treated with high doses of inhaled steroids, you may require additional steroid administration
  • if you have diabetes mellitus (Flusonal may increase blood sugar levels)
  • if your breathing worsens immediately after using this medicine, stop using it immediately and inform your doctor as soon as possible

Flusonal should not be used during acute attacks, but only as a long-term maintenance treatment. Discontinuation of the medicine should be carried out gradually.

Contact your doctor if you experience blurred vision or other visual disturbances.

Children and adolescents

Regular monitoring of height is advisable.

Other medicines and Flusonal 50 micrograms/inhalation

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines, including those obtained without a prescription.

Some medicines may increase the effects of Flusonal 50 micrograms/inhalation, so your doctor will monitor you closely if you are taking these medicines (including some used for HIV: ritonavir, cobicistat).

Oral medicines for the treatment of fungal infections (ketoconazole).

No interactions with other medicines have been reported. However, you should inform your doctor or pharmacist if you are taking or have taken medicines for the treatment of tuberculosis.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you might be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

It is unlikely that Flusonal will affect your ability to drive or operate machinery.

Warning for athletes

Athletes are advised that this medicine contains a component that may lead to a positive analytical finding in doping controls.

3. How to use Flusonal 50 micrograms/inhalation

Follow exactly the instructions for administering this medicine as given by your doctor. If in doubt, consult your doctor or pharmacist again.

Remember to use your medicine.

Your doctor will tell you how long to use Flusonal 50 micrograms/inhalation. Do not stop treatment earlier, even if you feel better.

It is important to inhale each dose exactly as directed by your doctor. The usual dose is:

Adults and adolescents over 16 years of age: 2 to 10 actuations twice daily (100 to 500 micrograms twice daily).

Children over 4 years of age: 1–2 actuations twice daily (50 to 100 micrograms twice daily).

Children from 1 to 4 years of age: 2 actuations twice daily (100 micrograms twice daily), administered via a paediatric spacer device with a face mask (such as a Babyhaler).

Your doctor will decide the dose, frequency of administration, and type of inhaler to be used.

Do not inhale more doses or use Flusonal 50 micrograms/inhalation more often than prescribed by your doctor.

This medicine may take several days to take effect. Therefore, it is very important to use it regularly. Inform your doctor and stop treatment if your breathing or wheezing worsens after using Flusonal 50 micrograms/inhalation. Inform your doctor if breathing difficulties or wheezing worsen or do not improve within 7 days, or if you notice you are increasing your use of other inhaled medicines.

Do not use this medicine to treat a sudden attack of breathlessness, as it will not help. For such attacks, you will need a different medicine. If you are using more than one medicine, be careful not to confuse them.

If you think the effect of this medicine is too strong or too weak, tell your doctor or pharmacist.

Instructions for correct use of Flusonal 50 micrograms/inhalation

Checking the inhaler:

Before using the inhaler for the first time, or if it has not been used for one week or longer, remove the mouthpiece protector by gently pressing the sides, shake the inhaler thoroughly, and release two doses into the air to ensure the inhaler is working properly.

Using the inhaler:

  1. Remove the mouthpiece protector by gently pressing the sides.
Two hands showing how to insert a black cap into a cylindrical medical device, indicated by a white arrow pointing toward the base
  1. Check that there are no foreign particles inside or outside the inhaler, including the mouthpiece.

  2. Shake the inhaler well to remove any foreign particles and ensure the contents are properly mixed.

A hand holding a cylindrical medical device with a curved white arrow indicating a rotational movement
  1. Hold the inhaler vertically between your index finger and thumb, placing your thumb on the base, below the mouthpiece.
Woman holding an inhaler near her mouth with two white arrows indicating the device's movement toward the mouth
  1. Breathe out as much air as reasonably possible, then place the mouthpiece in your mouth between your teeth, sealing your lips around it without biting.
A woman with light-colored hair holding an inhaler near her mouth, ready to use it
  1. Immediately after starting to inhale through your mouth, press the inhaler to release the fluticasone propionate, and continue inhaling deeply and steadily.
Woman in profile holding a small container near her mouth to take medication, with a white arrow indicating the direction
  1. Hold your breath and remove the inhaler from your mouth. Continue holding your breath as long as reasonably possible.
A woman holding an inhaler for respiratory treatment, looking at it carefully
  1. If a second inhalation is required, keep the inhaler upright and wait approximately half a minute before repeating steps 3 to 7.
  2. Afterwards, rinse your mouth with water and spit it out.
  3. Replace the mouthpiece protector by firmly pushing and fitting it into place until you hear a click.

Important

Do not carry out steps 5, 6, and 7 rapidly. It is important to start inhaling as slowly as possible, just before pressing the inhaler. Practice in front of a mirror during the first few times. If you see a "mist" escaping from the top of the inhaler or from the sides of the mouth, start again from step 2.

Patients who find it difficult to coordinate the use of the inhaler with inhalation may use an appropriate spacer device.

If your doctor has given you different instructions, follow them carefully. Consult your doctor or pharmacist if you have any difficulties.

Use in children:

Young children may need assistance, with an adult operating the inhaler for them. Encourage the child to breathe out, and then activate the inhaler immediately after the child begins to inhale. Practice the technique together.

Older children or individuals with weak hands should hold the inhaler with both hands; place both index fingers on the top of the inhaler and both thumbs under the base, below the mouthpiece.

Two hands holding vertically a dark cylindrical vial with a white cap to show its shape and size

Cleaning

Clean the inhaler at least once a week.

  • Remove the mouthpiece cap.

  • Do not remove the metal cartridge from the plastic casing.

  • Clean the inside and outside of the mouthpiece with a dry tissue or cloth.

  • Replace the mouthpiece cap.

Do not immerse the metal cartridge in water.

If you use more Flusonal 50 micrograms/inhalation than you should

If you have used more Flusonal 50 micrograms/inhalation than you should, contact the Poison Information Service, telephone 91 562 04 20, or immediately inform your doctor or go to the nearest hospital emergency department. Take this leaflet with you.

If you forget to use Flusonal 50 micrograms/inhalation

Do not inhale a double dose to make up for a missed dose. If you forget a dose, wait until your next scheduled dose.

If you stop using Flusonal 50 micrograms/inhalation

It is very important that you use this medicine every day as directed. Do not stop using Flusonal 50 micrograms/inhalation unless your doctor tells you to, as this could cause your breathing to worsen. Do not stop treatment with this medicine abruptly.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

Some people may develop fungal infections in the mouth (candidiasis) and experience sore throat or tongue, or hoarseness of voice after inhaling this medicine. To prevent this, it is recommended to brush your teeth or rinse your mouth or gargle with water and spit it out immediately after inhaling each dose. Inform your doctor, but do not stop treatment unless instructed to do so by your doctor.

If you experience any of the following symptoms after using Flusonal 50 micrograms/inhalation, stop using this medicine and contact your doctor immediately:

  • sudden wheezing or tightness in the chest
  • swelling of the eyelids, face, lips, tongue, or throat
  • skin rash (wheals) or hives anywhere on the body.

Other adverse effects include:

Very common (may affect more than 1 in 10 people)

  • candidiasis (fungal infection) in the mouth and throat.

Common (may affect up to 1 in 10 people)

  • pneumonia (lung infection) and bronchitis (inflammation of the airways) in patients with chronic obstructive pulmonary disease (COPD) (a disease that causes breathing difficulties).

Tell your doctor if you experience any of the following symptoms while inhaling fluticasone propionate. These could be symptoms of a lung infection:

  • fever or chills
  • increased mucus production, change in mucus color
  • increased cough or worsening breathing difficulties
  • hoarseness
  • bruising.

Uncommon (may affect up to 1 in 100 people)

  • skin hypersensitivity reactions.

Rare (may affect up to 1 in 1,000 people)

  • oesophageal candidiasis.

Very rare (may affect up to 1 in 10,000 people)

  • angioedema (skin reactions with erythema, swelling, and itching), mainly facial and oropharyngeal edema
  • respiratory symptoms such as dyspnea (feeling of breathlessness or difficulty breathing) and/or bronchospasm (narrowing of the bronchial walls with reduced airflow)
  • anaphylactic reactions (severe allergic reactions which may cause a sudden drop in blood pressure with loss of consciousness)
  • rounded face (moon face) (Cushing's syndrome)
  • suppression of adrenal gland activity, possibly causing fatigue, weight loss, nausea, vomiting, headache, low blood pressure, numbness, and seizures
  • growth retardation in children and adolescents
  • decreased bone mineral density
  • cataracts and glaucoma
  • hyperglycemia (increased blood glucose levels). If you have diabetes, you may need to monitor your blood sugar more frequently and possibly adjust your usual diabetes treatment
  • anxiety, sleep disorders, and behavioral changes including hyperactivity and irritability (mainly in children)
  • paradoxical bronchospasm (temporary narrowing of the bronchial walls with reduced airflow, occurring after using the inhaler).

Frequency not known

  • nosebleeds
  • blurred vision.

Reporting of adverse effects

If you experience any adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: www.notificaRAM.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Flusonal 50 micrograms/inhalation

Immediately after use, replace the mouthpiece protector by firmly pushing it into place until a click is heard. Do not use excessive force.

Do not store above 30°C. Do not freeze. Keep in the original packaging to protect from light.

If the inhaler is very cold, remove the cartridge and warm it with your hand for a few minutes before use. Do not use any other method to warm it.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.

Keep this medicine out of the sight and reach of children.

The cartridge contains pressurized liquid. Do not expose to temperatures above 50°C. Do not pierce, break, or burn the cartridge, even if it appears to be empty.

Medicines must not be disposed of via wastewater or household waste. Dispose of containers and unused medicines at the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Flusonal 50 micrograms/inhalation

  • The active substance is 50 micrograms of fluticasone propionate per dose.
  • The other component is norflurane q.s.

This medicinal product contains fluorinated greenhouse gases.

Each inhaler contains 10.6 g of HFC-134a (also known as norflurane or HFA 134a), equivalent to 0.0152 tonnes of CO2 (global warming potential GWP = 1,430).

Nature and contents of the container

Flusonal 50 micrograms/inhalation is a pressurised inhalation suspension, free from chlorofluorocarbon propellants. Each cartridge provides 120 doses.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

GlaxoSmithKline, S.A.

P.T.M. C/ Severo Ochoa, 2

28760 Tres Cantos (Madrid)

Tel: +34 900 202 700

[email protected]

Manufacturer:

Glaxo Wellcome Production S.A.S.
Zone Industrielle Nº 2
23 rue Lavoisier
27000 - Evreux
France

or

Glaxo Wellcome S.A.
Avenida Extremadura, 30
09400 Aranda de Duero (Burgos)
Spain

Date of the most recent revision of this leaflet: 01/2025

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/